Table 5 Follow-up data
|  | All patients (n = 65) | LGEA (n = 13) | Non-LGEA (n = 52) | p value* |
|---|---|---|---|---|
Follow-up duration | ||||
 Years of active follow-up, median (IQR)a | 5.5 (1.75–9.25) | 4.54 (0.80–9.25) | 5.5 (1.87–9.75) | 0.508 |
 Years of overall follow up, median (IQR)b | 5 (1.5–10) | 15 (1.04–20) | 5 (1.75–9.25) | 0.922 |
Readmissions | 53 (81.5%) | 9 (69.2%) | 44 (84.6%) | 0.237 |
 Number of readmissions, median (IQR) | 3 (1–6) | 3 (0–9.5) | 3 (1–6) | 0.735 |